Literature DB >> 23104172

Emphasising the European Union's Commitment to Cancer Research: a helicopter view of the Seventh Framework Programme for Research and Technological Development.

Jan-Willem van de Loo1, Dominika Trzaska, Karim Berkouk, Maria Vidal, Ruxandra Draghia-Akli.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23104172      PMCID: PMC3481902          DOI: 10.1634/theoncologist.2012-0327

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  22 in total

1.  Outlook for the next 5 years in drug innovation.

Authors:  Roy Berggren; Martin Møller; Rachel Moss; Pawel Poda; Katarzyna Smietana
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

2.  Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme.

Authors:  Stefan Jungbluth; Olaf Kelm; Jan-Willem van de Loo; Elengo Manoussaki; Maria Vidal; Manuel Hallen; Octavi Quintana Trias
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

3.  Trial watch: phase III and submission failures: 2007-2010.

Authors:  John Arrowsmith
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

4.  Mapping of signaling networks through synthetic genetic interaction analysis by RNAi.

Authors:  Thomas Horn; Thomas Sandmann; Bernd Fischer; Elin Axelsson; Wolfgang Huber; Michael Boutros
Journal:  Nat Methods       Date:  2011-03-06       Impact factor: 28.547

5.  Rare cancers are not so rare: the rare cancer burden in Europe.

Authors:  Gemma Gatta; Jan Maarten van der Zwan; Paolo G Casali; Sabine Siesling; Angelo Paolo Dei Tos; Ian Kunkler; Renée Otter; Lisa Licitra; Sandra Mallone; Andrea Tavilla; Annalisa Trama; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2011-10-25       Impact factor: 9.162

6.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

7.  Survival for cancer patients in Europe.

Authors:  Arduino Verdecchia; Mariano Santaquilani; Milena Sant
Journal:  Ann Ist Super Sanita       Date:  2009       Impact factor: 1.663

8.  Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice.

Authors:  Harri Lempiäinen; Arne Müller; Sarah Brasa; Soon-Siong Teo; Tim-Christoph Roloff; Laurent Morawiec; Natasa Zamurovic; Axel Vicart; Enrico Funhoff; Philippe Couttet; Dirk Schübeler; Olivier Grenet; Jennifer Marlowe; Jonathan Moggs; Rémi Terranova
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

9.  Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.

Authors:  Antonietta Silini; Carmen Ghilardi; Sara Figini; Fabio Sangalli; Robert Fruscio; Regine Dahse; R Barbara Pedley; Raffaella Giavazzi; MariaRosa Bani
Journal:  Cell Mol Life Sci       Date:  2011-12-01       Impact factor: 9.261

10.  Eurocan plus report: feasibility study for coordination of national cancer research activities.

Authors: 
Journal:  Ecancermedicalscience       Date:  2008-05-20
View more
  2 in total

Review 1.  Towards a mission-oriented approach to cancer in Europe: an unmet need in cancer research policy.

Authors:  Julio E Celis; Manuel Heitor
Journal:  Mol Oncol       Date:  2019-02-01       Impact factor: 6.603

2.  A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.

Authors:  Julio E Celis; Dainius Pavalkis
Journal:  Mol Oncol       Date:  2017-11-09       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.